Townsend Letter The Examiner of Alternative Medicine
Alternative Medicine Conference Calendar
Check recent tables of contents

 

From the Townsend Letter
June 2008

 

Longevity News and Review
by Ronald Klatz, MD, DO, and Robert Goldman, MD, PhD, DO, FAASP

Search this site
   

Online publication only

Longevity News and Review provides readers with the latest information in breakthroughs pertaining to the extension of the healthy human lifespan. These news summaries are compiled by the American Academy of Anti-Aging Medicine (A4M; www.worldhealth.net), a non-profit medical society composed of 20,000 physician and scientist members from 90 nations, united in a mission to advance biomedical technologies to detect, prevent, and treat aging-related disease and to promote research into methods to retard and optimize the human aging process. Ronald Klatz, MD, DO, A4M President and Robert Goldman, MD, PhD, DO, FAASP, A4M Chairman, physician co-founders of the anti-aging medical movement, distill these headlines and provide their insightful commentary.

Beta-Carotene Supplementation Benefits Aging Mens' Brains
In that oxidative stress contributes to age-related cognitive decline, antioxidant supplementation has been found to protect the brain. Francine Grodstein, of Harvard Medical School, and colleagues found long-term benefits for men taking beta-carotene supplements (50 mg every other day) for 15 or more years. Long-term beta-carotene supplementation was associated with a significantly higher score on tests of general cognition and verbal memory. Because beta-carotene is converted into vitamin A in the body, the team suggests that beta-carotenes exert their protective benefits on cognition by preventing the build-up of plaques associated with beta-amyloid deposits, which are associated with loss of cognitive function and an increased risk of Alzheimer's Disease.

Grodstein F, Kang JH, Glynn RJ, Cook NR, Gaziano JM. A randomized trial of beta-carotene supplementation and cognitive function in men: The Physicians' Health Study II. Arch Intern Med. 2007 Nov 12;167(20):2184-90.

Dr. Goldman remarks: "Upwards of 12 million people in the United States and European Union suffer from Alzheimer's. In the US alone, the disease costs more than $100 billion annually. This is the first study that looks at long-term antioxidant supplementation and how it can avert the cognitive decline so common in the aging population. It shows that beta-carotene should be considered as a critically important preventative measure to ward off cognitive decline, as supplementation is both safe and cost-effective over the long-term."

World's First Cloned Embryo from A Monkey – Are Humans Next?
Shoukhrat Mitalipov, of the Oregon Health and Science University (Beaverton, Oregon), and colleagues have created the world's first cloned embryo from a monkey. Using somatic cell nuclear transfer (SCNT), the same method that led to Dolly the Sheep and other genetically duplicated animals such as mice, pigs, cats, cows, and dogs, this marks the very first time a cloned primate has been successfully produced. Dr. Mitalipov harvested 304 eggs from 14 female monkeys and produced 35 early-stage embryos from the SCNT procedure; this, in turn, led to two lines of self-dividing embryonic stem cells. The researchers comment in their published paper that "Our results represent successful nuclear reprogramming of adult somatic cells into pluripotent embryonic stem cells and demonstrate proof-of-concept for therapeutic cloning in primates."

Byrne1 JA, Pedersen DA, Clepperl LL, Nelson M, Sanger WG, Gokhale S, Wolf DP, Mitalipov SM. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. Advance online publication 14 November 2007.

Dr. Klatz comments: "Dr. Mitalipov's breakthrough research paves the way for cloning of human cells for use in medical research and therapeutics. No longer do scientists need to harvest embryos to use in stem cell therapies; soon they will be able to be created in the laboratory without the ethical dilemmas currently plaguing stem cell therapeutics."

From Longevity News and Review; Volume 2007, Issue 6

 

Consult your doctor before using any of the treatments found within this site.

Subscriptions are available for Townsend Letter, the Examiner of Alternative Medicine magazine, which is published 10 times each year.

Search our pre-2001 archives for further information. Older issues of the printed magazine are also indexed for your convenience.
1983-2001 indices ; recent indices

Once you find the magazines you'd like to order, please use our convenient form, e-mail subscriptions@townsendletter.com, or call 360.385.6021 (PST).

 

Who are we? | New articles | Featured topics |
Tables of contents
| Subscriptions | Contact us | Links | Classifieds | Advertise | Alternative Medicine Conference Calendar | Search site | Archives |
EDTA Chelation Therapy | Home

 

© 1983-2008 Townsend Letter for Doctors & Patients
All rights reserved.
Website by Sandy Hershelman Designs
May 20, 2010

Order back issues
Advertise with TLDP!

Visit our pre-2001 archives